Spanish beauty group Puig used its first Capital Markets Day on Wednesday to lay out a long-term growth blueprint it calls “Vision 2032.” The company, known for brands like Charlotte Tilbury, Uriage, and its fragrance portfolio, is targeting annual revenue above €8 billion by 2032, alongside a profitability push that would see adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) exceed €1.8 billion—a margin above 22.5%.
The plan is mostly an organic growth story, but Puig is also signaling that deal-making remains a key part of its playbook. Management said it expects about €80 million in platform integration and acquisition synergies over the next three years, a sign the group is still knitting together a multi-brand portfolio. It also set a free cash flow target above €900 million by 2032, while keeping a dividend payout ratio of 40%.
What is Puig and why does this matter?
Puig is a Barcelona-based family-controlled company that owns and licenses a wide range of beauty and fragrance brands. It went public in 2024, and this Capital Markets Day was its first chance to give investors a detailed look at where the company is headed. For everyday investors, the event matters because it sets concrete financial targets that management will be judged against in the years ahead.
The company’s brand-level goals are ambitious. Charlotte Tilbury, the makeup brand Puig acquired a majority stake in, is expected to grow 1.5 times by 2032, with its own fragrance line launching from 2028. Uriage, a dermo-cosmetics brand, is targeted to double over the same period. These are the kind of specific milestones that help investors track whether the company is on course.
Deal-making still in the mix
Puig’s growth plan isn’t purely internal. The company is still pursuing acquisitions, particularly in premium fragrances. If its pending acquisition of ISDIN, a Spanish dermo-cosmetics company, is completed, Puig plans to combine ISDIN with Uriage and Apivita into a single dermo-cosmetics platform with over €1 billion in pro forma net revenue. That would broaden Puig’s revenue base beyond fragrances, which have been a strong driver but also a concentrated source of income.
Reuters has also reported that Puig is among the parties looking at Parfums de Marly, a luxury fragrance brand owned by private equity firm Advent International. While no deal is confirmed, the report underscores Puig’s appetite for premium fragrance assets. The company’s ability to fund such deals will be closely watched.
What it means for investors
For investors, the free cash flow target is more than just a number. A target above €900 million in 2032, combined with a 40% dividend payout ratio, suggests Puig could retain a meaningful chunk of cash after paying dividends. That internal funding can be a competitive edge in premium-fragrance mergers and acquisitions, where corporate buyers often compete with private equity firms and auctions can move quickly.
The €80 million in integration and acquisition synergies is part of the same credibility test. The more efficiently Puig turns its portfolio into cash, the less it may need to take on new debt or issue shares to stay active on deals. For investors, that can shape how believable the Vision 2032 margin and cash targets look if Puig also pursues assets like Parfums de Marly.
Puig’s targets come at a time when the broader beauty and fragrance industry is seeing strong demand, but also rising competition and input costs. Companies in this space often need to balance growth with margin protection, and Puig’s 22.5% adjusted EBITDA margin target is a clear signal that it intends to keep profitability a priority.
Investors will also be watching how Puig manages its multi-brand structure. The company has grown through acquisitions, and integrating brands like Charlotte Tilbury and Uriage into a cohesive portfolio is no small task. The €80 million synergy target is a modest but concrete commitment to making that integration work.
For those who own Puig shares or are considering them, the key takeaway is that management is setting clear, measurable goals. Whether those goals are met will depend on execution, market conditions, and the success of future deals. As with any long-term plan, the numbers are a guide, not a guarantee.
Puig’s Vision 2032 is a statement of intent: it wants to be a bigger, more profitable player in global beauty, with a strong presence in both fragrances and dermo-cosmetics. The company’s ability to deliver on its targets—and to fund its ambitions—will be the real test in the years ahead.
